Profile of Brazilian inpatients with COVID-19 vaccine breakthrough infection and risk factors for unfavorable outcome

Objective. To characterize the epidemiological and clinical profile of individuals more likely to become infected with SARS-CoV-2 after the fully vaccination schedule in order to profile priority groups to receive a booster dose in situations of vaccine doses shortage as well as for maintenance of p...

Full description

Bibliographic Details
Main Authors:	Matheus A. S. de Jesus, Natália S. Hojo-Souza, Thiago R. de Moraes, Daniel L. Guidoni, Fernanda S. H. de Souza
Format:	Article
Language:	English
Published:	Pan American Health Organization 2022-08-01
Series:	Revista Panamericana de Salud Pública
Subjects:	sars-cov-2 covid-19 vaccines risk factors brazil
Online Access:	https://iris.paho.org/handle/10665.2/56251

Similar Items

Clinical symptom profile of hospitalized COVID-19 Brazilian patients according to SARS-CoV-2 variants
by: Natália Satchiko Hojo-Souza, et al.
Published: (2023-08-01)

Risks of Adverse Outcomes for Hospitalized COVID-19 Patients during the Four Waves in Brazil According to SARS-CoV-2 Variants, Age Group, and Vaccine Status
by: Natália Satchiko Hojo-Souza, et al.
Published: (2023-09-01)

Profile and Outcomes of Hospitalized COVID-19 Patients during the Prevalence of the Omicron Variant According to the Brazilian Regions: A Retrospective Cohort Study from 2022
by: Pedro Dutra Drummond, et al.
Published: (2023-10-01)

COVID-19 Crisis in Brazil: Post-Vaccination Seroprevalence and Infection in More and Less Vaccinated Municipalities in a Northeastern State
by: Ronaldy Santana Santos, et al.
Published: (2024-01-01)

Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
by: Tafadzwa Dzinamarira, et al.
Published: (2022-02-01)

Overview of childhood vaccination coverage in Brazil and the impact of the COVID-19 pandemic: Is our children’s health at risk? A review of pre-COVID-19 periods and during the COVID-19 pandemic
by: Jéssica Paula Martins, et al.
Published: (2024-03-01)

Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
by: Sharon Walmsley, et al.
Published: (2023-12-01)

Prevalence and characteristics of COVID-19 vaccine breakthrough infection in Upper Egypt
by: Aliae A. R. Mohamed Hussein, et al.
Published: (2023-04-01)

A study about the number of Coronavirus breakthrough infections during post vaccination period
by: Sudhir Bhatia
Published: (2024-02-01)

Breakthrough SARS-CoV-2 infections after vaccination: a critical review
by: Zeinab Mohseni Afshar, et al.
Published: (2022-11-01)

Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
by: Jonny Jonny, et al.
Published: (2022-09-01)

Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
by: Andrea Lombardi, et al.
Published: (2024-03-01)

Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India
by: Arup Ghosh, et al.
Published: (2022-06-01)

The “identikit” of subject with obesity and COVID-19 vaccine breakthrough
by: Giovanna Muscogiuri, et al.
Published: (2022-04-01)

Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina
by: Diane Uschner, et al.
Published: (2022-11-01)

Psychometric properties and reliability of the Brazilian version of Parent Attitudes about Childhood Vaccine (PACV-BR)
by: Claudio José dos Santos Júnior, et al.
Published: (2023-09-01)

Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
by: Adeel A. Butt, MBBS, MS, et al.
Published: (2021-09-01)

Predicting the Disease Outcome in COVID-19 Positive Patients Through Machine Learning: A Retrospective Cohort Study With Brazilian Data
by: Fernanda Sumika Hojo De Souza , et al.
Published: (2021-08-01)

Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection
by: Sonja H. Brunvoll, et al.
Published: (2023-01-01)

Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population
by: Adeel A. Butt, et al.
Published: (2021-10-01)

Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium
by: Veerle Stouten, et al.
Published: (2022-04-01)

Postvaccination breakthrough SARS-CoV-2 infections among adults in Malaysia and attitudes towards future vaccination
by: Praneetha Kumar Nair, et al.
Published: (2023-01-01)

SARS-CoV-2 testing disparities across geographical regions from a large metropolitan area in Brazil: Results from a web-based survey among individuals interested in clinical trials for COVID-19 vaccines
by: Thiago S. Torres, et al.
Published: (2021-07-01)

Hesitation to vaccination for COVID-19 among the Brazilian adult population
by: Henrique Pott Junior, et al.
Published: (2023-04-01)

Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study
by: Amit Bahl, et al.
Published: (2021-12-01)

COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients
by: Xiaojing Zhang, et al.
Published: (2022-11-01)

Severe acute respiratory syndrome coronavirus 2 vaccine breakthrough infections: A single metro-based testing network experience
by: Samantha S. Strickler, et al.
Published: (2022-11-01)

Effect of second booster vaccination on clinical outcomes of Omicron-variant breakthrough infection: A propensity score matching cohort study
by: Denggao Peng, et al.
Published: (2024-01-01)

COVID-19 pandemic outbreak: the Brazilian reality from the first case to the collapse of health services
by: CRISTIANE M.L. DE MELO, et al.
Published: (2020-08-01)

Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type
by: Jozef Dingemans, et al.
Published: (2022-11-01)

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations
by: Thomas Perkmann, et al.
Published: (2023-08-01)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
by: Ye-Fan Hu, et al.
Published: (2022-03-01)

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness
by: Reynolds MW, et al.
Published: (2022-09-01)

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine
by: Luisa F. Duarte, et al.
Published: (2021-09-01)

Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
by: Krystallenia Paniskaki, et al.
Published: (2022-01-01)

Pharmacovigilance in Brazil: The Government Monitoring of Adverse Events Reported from COVID-19 Vaccine—A Narrative Review
by: Mariana Carvalho de Moraes, et al.
Published: (2024-02-01)

Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review
by: Shilpa Gopinath, et al.
Published: (2022-05-01)

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection
by: Disha Bhavsar, et al.
Published: (2023-12-01)

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
by: Jing Zou, et al.
Published: (2022-08-01)

The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines
by: Bruna Aparecida Souza Machado, et al.
Published: (2022-04-01)